IL-6 is a pleiotropic cytokine that not only regulates the immune and inflammatory response but also affects renal-resident cells, including podocytes, mesangial cells, endothelial cells, and tubular epithelial cells making this molecule as a promising therapeutic target during CKD [35]. This evidence concerns the gene IL6 and chronic kidney disease.